Resources
31 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 11/9/2023 (updated 3/28/2024)
The CDC has released updated HCV testing recommendations perinatally exposed infants and children.
Posted 11/9/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) published Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants in 2018. The National Center on Substance Abuse and Child Welfare (NCSACW) developed companion materials that offer information and strategies to support pregnant and parenting people with substance use disorders (SUDs) in the child welfare system.
Posted 10/15/2023 (updated 3/27/2024)
The University of Rochester Recovery Center of Excellence, one of three FORHP-supported Rural Centers of Excellence on Substance Use Disorder, has developed comprehensive training on the treatment of opioid use disorder (OUD) in primary care. This no-cost training prepares providers and staff to deliver evidence-based care to patients. Continuing education credits are available.
Posted 9/29/2023 (updated 3/27/2024)
The 2023 RCORP-Overdose Response Onboarding Packet contains strategies and resources to assist grantees in the implementation of your new Overdose Response (OR) grant. The Onboarding Packet includes tools to support grant-funded activities, along with information on accessing TA.
Posted 6/18/2023 (updated 3/28/2024)
This report provides information on the results of the Cherokee Nation Health Services' (CNHS) hepatitis C elimination program 5 years after implementation. The report finds that the program had success with 99% of patients who completed treatment.
Posted 3/29/2023 (updated 3/27/2024)
The University of Rochester Medicine Recovery Center of Excellence is offering free trainings to provide guidance on evidence-based strategies to work through resistance and encourage help-seeking behavior. Cognitive Behavioral Therapy for Treatment Seeking (CBT-TS) is an evidence-based technique to encourage help seeking among those in need.
Posted 2/14/2023 (updated 3/27/2024)
This systematic review of peer-reviewed literature that held controlled trails which examined a pharmacological treatment for amphetamine/methamphetamine dependence or use disorder. The article found that most studies were underpowered and had low completion rates, with others showing that no pharmacotherapy produced results for the treatment of amphetamine/methamphetamine dependence.
Posted 1/17/2023 (updated 3/27/2024)
The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.
Posted 10/25/2022 (updated 3/27/2024)
Hepatitis C: State of Medicaid Access is a collaboration between the Center for Health Law and Policy Innovation of Harvard
Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR). The project evaluates hepatitis C (HCV)
treatment restriction policies across state Medicaid programs, including all 50 states, the District of Columbia, and Puerto
Rico (referred to in this report as “states”). The goal of this project is to encourage states and empower advocates to work
toward improved access to curative HCV treatment across all Medicaid programs, in order to ensure that every Medicaid
enrollee who can benefit from this treatment is able to access it.
Posted 3/22/2022 (updated 3/27/2024)
Infective endocarditis is a life-threatening inflammation of the heart’s chambers and valves that can be difficult and expensive to treat. Like hepatitis and HIV, infective endocarditis can be caused by using needles that are not sterile. This infographic highlights basic information about infective endocarditis alongside an anatomical image of a human heart.